Crossmark

Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report

Crossref DOI link: https://doi.org/10.1186/s12895-018-0077-x

Published Online: 2018-10-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cherrez-Ojeda, Ivan http://orcid.org/0000-0002-1610-239X
Vanegas, Emanuel

Felix, Miguel

Mata, Valeria L.

Cherrez, Annia
License Information

Text and Data Mining valid from 2018-10-25
More Information

Article History

Received: 2 March 2018

Accepted: 10 October 2018

First Online: 25 October 2018

Ethics approval and consent to participate

: Not applicable

: Written informed consent was obtained from the patient for publication of this Case report and all accompanying images. A copy of the written consent is available for review by the Series Editor of this journal if requested.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.